news – Page 11 – Medxy AI

Evaluating Cost-Effectiveness of Accelerated Versus Standard Initiation of Renal Replacement Therapy in Severe Acute Kidney Injury

By MedXY 10/05/2025

This analysis reveals that standard initiation of kidney replacement therapy (KRT) in critically ill patients with severe acute kidney injury (AKI) offers greater quality-adjusted life years (QALYs) at an acceptable increased cost, suggesting cost-effectiveness in Canadian healthcare settings.

Internal Medicine news Public Health

Support for Alcohol Control Policies Among US Alcohol Consumers

By MedXY 10/04/2025

Many US adults who consume alcohol support policies like cancer warnings and advertising restrictions on alcohol, with demographic variations in support levels.

news OB/GYN & Women's Health Oncology Radiology Specialties

Impact of Immediate Past Mammography Participation on Outcomes of Screen-Detected Breast Cancer

By MedXY 10/04/2025

This cohort study reveals that women with screen-detected breast cancer who missed the immediate prior mammography screening have larger tumors, more advanced disease, and worse breast cancer-specific survival, suggesting delayed detection and poorer prognosis.

Infectious Diseases news Pediatrics

Evaluating the Incremental Benefit of Two Versus One Dose of Influenza Vaccine in Influenza-Naive Children Under Nine: A Systematic Review and Meta-Analysis

By MedXY 10/04/2025

This systematic review and meta-analysis assess the additional protection from a second dose of influenza vaccine in vaccine-naive children under nine years old, highlighting significant benefits particularly for those under three years.

Neurology news

Balancing Act in Traumatic Acute Subdural Hematoma: Acute Surgery vs Conservative Management

By MedXY 10/04/2025

A multicenter study found no superior outcomes between acute surgical evacuation and conservative treatment for traumatic acute subdural hematoma, suggesting conservative management may be appropriate when surgical equipoise exists.

AI Dermatology Infectious Diseases news Specialties

Harnessing Artificial Intelligence for Diagnosing Sexually Transmitted Infections and Anogenital Dermatoses: Insights from a Systematic Review and Meta-Analysis

By MedXY 10/04/2025

AI demonstrates high accuracy in identifying mpox and other anogenital conditions from clinical images, yet significant research gaps and validation needs remain before clinical adoption.

General Surgery news Oncology

Defining Cure in Stage II-III Colon Cancer: Insights from a Pooled Analysis of 15 Randomized Trials

By MedXY 10/04/2025

A rigorous pooled analysis of over 35,000 patients identifies a recurrence risk below 0.5% at 6 years post-surgery, providing a practical benchmark for defining cure in stage II-III colon cancer and refining patient management strategies.

news Oncology Otorhinolaryngology

Evaluating Partial versus Whole Laryngeal Radiotherapy in Early-Stage Laryngeal Carcinoma: A Retrospective Cohort Analysis

By MedXY 10/04/2025

This study compares partial laryngeal radiotherapy (PLRT) and whole laryngeal radiotherapy (WLRT) in T1-2N0M0/Tis laryngeal carcinoma, demonstrating comparable locoregional control but less acute toxicity with PLRT, though longer follow-up is needed.

Infectious Diseases news Respiratory

Three-Season Protection Against RSV in Older Adults: Insights from the AReSVi-006 Phase 3 Trial of the AS01E-Adjuvanted RSVPreF3 OA Vaccine

By MedXY 10/04/2025

The AS01E-adjuvanted RSVPreF3 OA vaccine demonstrates robust efficacy against RSV-related lower respiratory tract disease over three seasons in adults aged 60+, with a favorable safety profile and promising immunogenicity findings.

Infectious Diseases news Respiratory Specialties

Evaluating the Safety and Immunogenicity of the Adjuvanted RSVPreF3 Vaccine in High-Risk Transplant Recipients: A Critical Analysis of an Interventional Cohort Study

By MedXY 10/04/2025

This study assesses the safety and immune response of an adjuvanted RSVPreF3 vaccine in adult allogeneic hematopoietic cell and lung transplant recipients, highlighting modest antibody responses but robust CD4+ T-cell activation, supporting vaccination benefits amidst immunocompromised risks.

news Oncology Radiology Specialties Urology

PSMA PET-Guided Intensification of Salvage Radiotherapy Enhances Outcomes Post-Radical Prostatectomy: Insights from a Phase 2 RCT

By MedXY 10/04/2025

A phase 2 randomized trial demonstrates that PSMA-PET-guided intensification of salvage radiotherapy after radical prostatectomy significantly improves failure-free survival without added toxicity.

Neurology news Otorhinolaryngology

Unraveling the Link Between Anxiety and Dizziness in Vestibular Schwannoma Patients: Insights From a Retrospective Cohort Study

By MedXY 10/04/2025

A recent study reveals that anxiety significantly correlates with increased dizziness severity in patients with vestibular schwannoma, highlighting an underexplored psychological dimension in symptom burden and prompting calls for integrated management approaches.

Internal Medicine news Respiratory

Evaluating Hypertonic Saline and Carbocisteine in Non-Cystic Fibrosis Bronchiectasis: Insights from the CLEAR Trial

By MedXY 10/04/2025

This article reviews a robust UK trial assessing hypertonic saline and carbocisteine in bronchiectasis, revealing no significant reduction in pulmonary exacerbations over 52 weeks, highlighting the need for continued research on mucoactive therapies.

Cardiology Infectious Diseases news

Evaluating Cardiovascular-Focused Messaging to Enhance Influenza Vaccination Uptake in Diverse U.S. Populations

By MedXY 10/03/2025

A large randomized trial in the U.S. found no significant improvement in influenza vaccination rates with cardiovascular-focused messaging compared to usual care, despite prior positive findings in Denmark.

Gastroenterology Infectious Diseases news Pediatrics

Revisiting Rehydration Strategies in Severe Acute Malnutrition with Gastroenteritis: Intravenous Versus Oral Approaches

By MedXY 10/03/2025

A recent trial assessing intravenous versus oral rehydration in children with severe acute malnutrition and gastroenteritis found no mortality difference at 96 hours, challenging fears of fluid overload and supporting cautious consideration of intravenous therapy.

Cardiology Clinical Updates news Specialties

Targeting APOC3 with Olezarsen in Moderate Hypertriglyceridemia: Advances in Antisense Therapies for Triglyceride Reduction

By MedXY 10/03/2025

Olezarsen, a GalNAc-conjugated antisense oligonucleotide targeting APOC3 mRNA, significantly reduces triglyceride levels in moderate hypertriglyceridemia, offering a promising therapeutic advance with favorable safety in cardiovascular risk patients.

Cardiology news Public Health

Transforming Hypertension Management: Home-Based Care Success in Rural South Africa

By MedXY 10/03/2025

A randomized trial in rural South Africa showed home-based hypertension care with community health workers and mobile technology significantly lowered systolic blood pressure and improved control versus standard clinic care at 6 and 12 months.

Medical News news Public Health Specialties

Predicting Nobel Laureates: Experts Weigh In on the 2025 Nobel Prize Contenders

By MedXY 10/02/2025

Scientists share insights on leading Nobel Prize contenders like leptin discoverer Jeffrey Friedman, pioneer of protein phase separation Anthony Hyman, and optogenetics innovator Karl Deisseroth ahead of the 2025 announcements.

Gastroenterology news Specialties

Primary Sclerosing Cholangitis in a 45-Year-Old Male: A Case Report

By MedXY 10/02/2025

A 45-year-old male presents with cholestatic liver enzyme elevation and pruritus, diagnosed with primary sclerosing cholangitis confirmed by imaging and liver biopsy. Clinical management and prognosis are discussed.

Clinical Updates news Psychiatry Specialties

Balancing Risks and Benefits: Early Antipsychotic Dose Reduction Versus Maintenance After First-Episode Psychosis Remission

By MedXY 10/01/2025

A randomized clinical trial reveals early dose reduction of antipsychotics after first-episode psychosis remission increases short-term relapse risk and lowers quality of life, but may improve long-term functioning over four years.